Book Value Per Share: The amount of equity available to shareholders expressed on a per common share basis. Calculated as: Total Shareholders Equity / Common Shares Outstanding
Salarius Pharmaceuticals, Inc. (SLRX) had Book Value Per Share of $0.03 for the most recently reported fiscal quarter, ending 2025-03-31.
Income Statement Financials | |
-- |
|
$-1.71M |
|
-- |
|
-- |
|
$1.72M |
|
$-1.72M |
|
$0.01M |
|
$-1.71M |
|
$-1.71M |
|
$-1.71M |
|
$-1.71M |
|
$-1.71M |
|
$-1.71M |
|
$-1.72M |
|
$-1.72M |
|
1.66M |
|
1.66M |
|
$-1.03 |
|
$-1.03 |
|
Balance Sheet Financials | |
$2.31M |
|
-- |
|
$0.03M |
|
$2.34M |
|
$2.28M |
|
-- |
|
-- |
|
$2.28M |
|
$0.06M |
|
$0.06M |
|
$0.06M |
|
2.08M |
|
Cash Flow Statement Financials | |
$-1.18M |
|
-- |
|
$0.55M |
|
$2.43M |
|
$1.80M |
|
$-0.64M |
|
-- |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
1.01 |
|
-- |
|
-- |
|
-- |
|
1.81 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.18M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-2763.25% |
|
-2763.28% |
|
-73.08% |
|
-2763.28% |
|
Book Value Per Share |
$0.03 |
$-0.71 |
|
$-0.71 |